BHVN

Biohaven Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth 4/10
  • Value 4/10
Biohaven sales and earnings growth
BHVN Growth
Neutral
  • Revenue Y/Y 0.00%
  • EPS Y/Y 39.94%
  • FCF Y/Y 8.40%
Biohaven gross and profit margin trends
BHVN Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 5Y -248.44%
Biohaven net debt vs free cash flow
BHVN Risk
Fair
  • Debt / Equity 2.2
  • Debt / FCF 0.0
  • Interest coverage NA

Biohaven stock volatility is in-line with the overall market. We give it a Fair risk rating.

↗ More Biotechnology stocks